Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Leukemia and lymphoma
Year: 2017, Volume: 58, Issue: 12, Pages: 2824-2832 |
| ISSN: | 1029-2403 |
| DOI: | 10.1080/10428194.2017.1326034 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1080/10428194.2017.1326034
|
| Author Notes: | Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun-Fang Chiou, Joris Diels and Martin Dreyling |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576296202 | ||
| 003 | DE-627 | ||
| 005 | 20220814161829.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180612s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2017.1326034 |2 doi | |
| 035 | |a (DE-627)1576296202 | ||
| 035 | |a (DE-576)506296202 | ||
| 035 | |a (DE-599)BSZ506296202 | ||
| 035 | |a (OCoLC)1341011317 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heß, Georg |d 1966- |e VerfasserIn |0 (DE-588)136395384 |0 (DE-627)582073677 |0 (DE-576)300998082 |4 aut | |
| 245 | 1 | 0 | |a Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus |c Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun-Fang Chiou, Joris Diels and Martin Dreyling |
| 264 | 1 | |c 2017 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 30 May 2017 | ||
| 500 | |a Gesehen am 12.06.2018 | ||
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia and lymphoma |d London [u.a.] : Taylor & Francis Group, 1989 |g 58(2017), 12, Seite 2824-2832 |h Online-Ressource |w (DE-627)324746237 |w (DE-600)2030637-4 |w (DE-576)099718170 |x 1029-2403 |7 nnas |a Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus |
| 773 | 1 | 8 | |g volume:58 |g year:2017 |g number:12 |g pages:2824-2832 |g extent:7 |a Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus |
| 856 | 4 | 0 | |u https://doi.org/10.1080/10428194.2017.1326034 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180612 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 60000 |d 61400 |e 60000PW1050736516 |e 61400PW1050736516 |k 0/60000/ |k 1/60000/61400/ |p 9 | ||
| 999 | |a KXP-PPN1576296202 |e 3012552928 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus","title_sort":"Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus"}],"person":[{"family":"Heß","given":"Georg","display":"Heß, Georg","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Witzens-Harig, Mathias","roleDisplay":"VerfasserIn","role":"aut","family":"Witzens-Harig","given":"Mathias"}],"note":["Published online: 30 May 2017","Gesehen am 12.06.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1576296202","language":["eng"],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"id":{"doi":["10.1080/10428194.2017.1326034"],"eki":["1576296202"]},"name":{"displayForm":["Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun-Fang Chiou, Joris Diels and Martin Dreyling"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1029-2403"],"zdb":["2030637-4"],"eki":["324746237"]},"origin":[{"publisherPlace":"London [u.a.] ; London [u.a.]","publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedKey":"1989","dateIssuedDisp":"1989-"}],"recId":"324746237","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 08.09.15"],"disp":"Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimusLeukemia and lymphoma","part":{"year":"2017","issue":"12","pages":"2824-2832","text":"58(2017), 12, Seite 2824-2832","volume":"58","extent":"7"},"pubHistory":["1.1989/90 -"],"title":[{"title_sort":"Leukemia and lymphoma","title":"Leukemia and lymphoma"}]}]} | ||
| SRT | |a HESSGEORGWHEALTHRELA2017 | ||